Global In-Vitro Diagnostics Market Overview

The global In-vitro diagnosis market was valued at USD 63.5 billion in 2018 and t is expected to grow at a healthy CAGR of 4.0% during 2019-2026.
Market Scenario
In-vitro diagnosis is the technique used to identification of disease, infection and other genetic conditions. A variety of techniques are developed for the monitoring process. The global in-vitro diagnosis market is majorly driven by increasing prevalence of chronic & infectious diseases, technological advances and rising geriatric population. During last decade, there is a significant increase in the number of patients suffering from diabetes. According to the World Health Organization (WHO), in 2014, 422 million people across the globe are suffering from diabetes. This has led to increase in the number of public and private diagnostic centers across the globe which has boosted the growth of the market. Moreover, increasing healthcare expenditure and government initiatives have fueled the growth of the market.
However, stringent government regulations for IVD products and reagents and poor reimbursement policies may slow the growth of the market during the forecasted period. Emerging economies are increasing the investments in research sector with rapidly increasing demand for the better diagnostic test have served as a opportunity for the development of the market. 
The global In-vitro diagnostics market is expected to grow at a steady CAGR of 4.9% during 2018-2026.
The global in-vitro diagnostics market is segmented based on products, techniques, applications and end users.
Based on products, the market is segmented into reagents, instruments, software & services.
Based on techniques, the market is segmented into immunodiagnostics, blood glucose monitoring, point-of-care, molecular diagnostics, tissue diagnostics, and others.
Based on application, the market is segmented into diabetic care, infectious diseases, cancer, nephrological diseases, immune system disorders, gastrointestinal diseases.
Based on end users, the market is segmented into hospitals & clinics, research laboratories, and others.
Regional Analysis
The global in-vitro market is dominated by America owing well developed technology, high healthcare spending and huge patient population suffering from diabetes and cancer. Additionally, presences of geriatric population and government support have fuelled the market growth in America. 
Europe accounts for the second leading market which is followed by Asia Pacific. Strong government support and favorable research policies have driven the growth of Europe market. Germany dominates the Europe IVD market. In 2017, the German IVD-Market witnessed slight decline in the sales. However, the market development differed strongly between the various segments. Laboratory diagnostics continue to increase similarly to the previous years. A major decline can be found for the rapid market where the negative market trend of 2016 continues. After 2017, German market has been witnessing significant growth due to several factors. Major factors include, restrictive legal framework that forces medical doctors to prescribe generic, low-priced test strips to not overstep their respective budget remains in place. In addition to this, the shift to new sensor-based technologies for the measurement of glucose continues in Germany. Until the flash glucose monitoring / continuous glucose monitoring is not included in the GIVD classification and due to the current market situation with only a very few numbers of competitors, the positive development of these technologies cannot be reproduced exactly. Still, regulatory environment in Germany remains strict. The floating quota percentage for laboratory service fees remains in place and unchanged in 2017. Consequently, price pressure does stay strong in the German IVD-Market. However, despite this various market segments continue to thrive.
Asia Pacific is the fastest growing market due to huge untapped opportunity for the development of the market. 
On the other hand, the Middle East & Africa holds the least share in the market due to presence of poor economies in Africa region.
Key Players
The key players in the market are: F. Hoffmann-La Roche Ltd (Switzerland), Danaher (U.S.), Abbott Laboratories (U.S.), Siemens Healthcare GmbH (Germany), QIAGEN (Germany), Johnson & Johnson Services, Inc. (U.S.), Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Alere (U.S.), and Ortho Clinical Diagnostics (U.S.)
Global In-Vitro Diagnostics Market, By Products
Software and Services
Global In-Vitro Diagnostics Market, By Techniques
Enzyme-Linked Immunosorbent Assay (ELISA)    
Chemiluminescence Immunoassays (CLIAS)
Fluorescence Immunoassays (FIAS)
Colorimetric Immunoassays (CIS)
Enzyme-Linked Immunospot Assays (ELISPOT)    
Western Blot    
Blood Glucose Monitoring
Point of Care
Molecular Diagnostics
Polymerase Chain Reaction (PCR)    
DNA Diagnostics
Tissue Diagnostics
Immunohistochemistry (IHC) test
Fluorescent in situ hybridization (FISH)
Silver in situ hybridization (SISH)
By Application
Diabetic Care
Infectious Diseases
Nephrological Diseases
Immune System Disorders
Gastrointestinal Diseases
Global In-Vitro Diagnostics Market, By End Users
Hospitals & Clinics
Research Laboratories
Global In-Vitro Diagnostics Market players
F. Hoffmann-La Roche Ltd 
Abbott Laboratories
Siemens Healthcare GmbH 
Johnson & Johnson Services, Inc.
Thermo Fisher Scientific
Bio-Rad Laboratories, Inc.
Dickinson and Company
Ortho Clinical Diagnostics (U.S.)

1.    Introduction
1.1.    Market Definition
1.2.    Market Scope
2.    Research Methodology
2.1.    Primary Research
2.2.    Secondary Sources
2.3.    Assumptions & Exclusions
3.    Market Overview
3.1.    Segmentation & Scope
3.2.    Value Chain Analysis 
3.3.    Key Market Trend Analysis
3.3.1.    Market Drivers
3.3.2.    Market Restraint/Challenges
3.3.3.    Market Opportunities
3.4.    Porter’s Five Forces Analysis
3.5.    Potential Venture Avenues
3.6.    Market Share Analysis, 2016 
3.7.    Market Overview – In-Vitro Diagnostics
3.8.    Regulatory Framework
3.9.    EU IVD market for 28 Countries
3.10.    Pipeline Analysis
4.    Product Overview
4.1.    Introduction
4.2.    Market Size & Forecast, 2016 to 2026
4.2.1.    Reagents
4.2.2.    Instruments
4.2.3.    Software and Services
5.    Techniques Overview
5.1.    Introduction 
5.2.    Market Size & Forecast, 2016 to 2026
5.2.1.    Immunodiagnostics    Enzyme-Linked Immunosorbent Assay (ELISA)    Chemiluminescence Immunoassays (CLIAS)    Fluorescence Immunoassays (FIAS)    Colorimetric Immunoassays (CIS)    Others    Enzyme-Linked Immunospot Assays (ELISPOT)    Radioimmunoassay    Western Blot    Others 
5.2.2.    Blood Glucose Monitoring
5.2.3.    Point of Care
5.2.4.    Molecular Diagnostics    Polymerase Chain Reaction (PCR)    Hybridization    DNA Diagnostics    Microarrays    Others
5.2.5.    Tissue Diagnostics    Immunohistochemistry (IHC) test    Fluorescent in situ hybridization (FISH)    Silver in situ hybridization (SISH)    Others
5.2.6.    Others
6.    Applications Overview
6.1.    Introduction
6.2.    Market Size & Forecast, 2016 to 2026
6.2.1.    Diabetic Care
6.2.2.    Infectious Diseases
6.2.3.    Cancer
6.2.4.    Nephrological Diseases
6.2.5.    Immune System Disorders
6.2.6.    Gastrointestinal Diseases
6.2.7.    Other
7.    End Users Overview
7.1.    Introduction
7.2.    Market Size & Forecast, 2016 to 2026
7.2.1.    Hospitals & clinics
7.2.2.    Research Laboratories
7.2.3.    Others
8.    Regional Overview
8.1.    Introduction
8.2.    Market Size & Forecast, 2016 to 2026
8.2.1.    Americas    North America    U.S.    Canada    South America
8.2.2.    Europe    Western Europe    Germany    France    U.K.    Italy    Spain    Rest Of Western Europe    Eastern Europe
8.2.3.    Asia Pacific    Japan    China    India    Australia    Rest of Asia Pacific
8.2.4.    The Middle East & Africa    The Middle East    UAE    Saudi Arabia    Qatar    Rest of the Middle East    Africa
9.    Manufacturer/ Vendor Profile
9.1.    The following attributes will be considered while profiling key manufacturers in this industry: 
9.1.1.    Company Overview
9.1.2.    Financial Synopsis
9.1.3.    Recent Developments
9.1.4.    R&D Investments (if any)
9.1.5.    Strategy Overview (Analyst Perspective)
9.1.6.    Product Portfolio
9.2.    Companies Profiled
9.2.1.    F. Hoffmann-La Roche Ltd
9.2.2.    Danaher
9.2.3.    Abbott Laboratories
9.2.4.    Siemens Healthcare GmbH
9.2.5.    QIAGEN
9.2.6.    Johnson & Johnson Services, Inc.
9.2.7.    Thermo Fisher Scientific
9.2.8.    Bio-Rad Laboratories, Inc.
9.2.9.    Becton, Dickinson and Company
9.2.10.    Alere
9.2.11.    Ortho Clinical Diagnostics

Let us know more about your research need and we will customize an offer exclusively for you!
Let us know more about your research need and we will customize an offer exclusively for you!
Please Select Format
Enquiry About Report

More Information

Contact us
+1 321-441-4414
--- or ---


  • Linda Jacobson
    Director of Product Development

    Medical Devices manufacturing company at Canada

    I was looking for some elaborated details on blood bag got a reference from my colleague about them, and I was very much satisfied with the data on market segmentation and insights about global market, asked them if I can get it more customised hence they did elaborated it to huge 400 pages deep report in one week.Thanks guys will be back in future.

  • Mike Simmons
    Purchase Head

    Heavy machinery manufacturing company

    Did purchased a report from one of the vendor on Artificial Lift Market and I was depressed to see the very standard type of data included in the report, then again went back to hunt for something valuable and data driven report they asked me each and every details I want to see over the report and after a week of time got what I was looking for so not hesitant to refer back to them. Thanks victor for being prompt and professional.

  • Anna Stevenson
    Business Owner

    freelance software developer

    It’s been 8 years now I am developing and designing software as a freelance for various small and large scale organisations around globe and wanted to start my own software development consultancy firm, and I got hooked to their Mobile application market report and after a very thorough understanding of the report I have stepped my start-up into the customised mobile software market at Middle East, Africa and Asia Pacific.Thanks to Lee the Boss analyst  and victor for small discount.

  • Josh Bernard
    Owner, Designer, Artist

    Deals on customised automobile at USA

    I am one of the biggest enthusiast for custom jobs on cars, trucks and ships since childhood, so I own a custom automobile designing company and I was blown off to see beautiful custom paint work done on a Ford at one of the event and since that day I wanted to offer the same to my clients as well but I was not having too much of information on Electric paints, and fortunately I received message on LinkedIn from Data N Analysis team about their service, and now I am stuck  with three research report and contract signed for digital marketing as well. (Best of luck guys).

  • Neo Yang
    Chief Technical Officer

    Electronics Manufacturing company at Malaysia.

    Great team to have as a consultant, very sensible and professional service provided as per the scheduled timeline, what I like most about them is that they are straight forward with quality of service so if you are in hurry they will just say sorry we can’t compromise with our work. Look forward for more inputs guy’s thanks.